Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Risk Factors for Melanoma Among Survivors of Non-Hodgkin LymphomaClara J K Lam, Rochelle E Curtis, Graça M Dores, et al.
Leukemia & Lymphoma|June 1, 2010
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approachesMonika Engelhardt, Martina Kleber, Josefina Udi, et al.
Blood|April 17, 2014
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLLChristian H Geisler, Mars B van T' Veer, Jesper Jurlander, et al.
Leukemia & Lymphoma|August 4, 2016
The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemiaFie Juhl Vojdeman, Mars B Van't Veer, Geir E Tjønnfjord, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
T-cell lymphomas in South america and europeMonica Bellei, Carlos Sergio Chiattone, Stefano Luminari, et al.
Leukemia & Lymphoma|March 11, 2017
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemiaFie J Vojdeman, Sarah E M Herman, Nikolai Kirkby, et al.
Leukemia & Lymphoma|September 3, 2010
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myelomaMonika Engelhardt, Josefina Udi, Martina Kleber, et al.
The New England Journal of Medicine|December 8, 2015
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A Burger, Alessandra Tedeschi, Paul M Barr, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2016
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trialsMassimo Gentile, Katja Zirlik, Stefania Ciolli, et al.
Leukemia|May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelinesMichael Grever, Leslie Andritsos, Versha Banerji, et al.
Pageof 12